Calling the Situation Grim, the Supreme Court Takes Suo Motu Cognizance of Delays in NCLT Approvals || Supreme Court: Admission of a Claim by a Resolution Professional is Not Debt Acknowledgment || Supreme Court: Public Figures Must Exercise Caution as Their Words Have Consequences in Society || SC: State Must Act as a Model Employer, Criticising the Union For Not Regularising ISRO Workers || J&K&L High Court: Minor Minerals Have Major Environmental Impacts and Must be Regulated || Del HC: Unexplained Money Received by Public Servant is Not Bribery Without Proof of Official Favour || Del HC: There is No Absolute Bar on Granting Co-Convicts Parole/Furlough Together in Suitable Cases || Bom HC: LARR Authority Can Examine Limitation Issues in Land Acquisition References under 2013 Act || MP HC: Long-Serving Employees Cannot Be Denied Regularisation by Retrospective Statutory Amendments || J&K&L HC: Routine Challenges to Lok Adalat Awards Defeat Their Purpose of Quick Dispute Resolution

Drugs and Cosmetics (Amendment) Bill, 2015 - (30 Nov 2015)

Miscellaneous

The Drugs and Cosmetics (Amendment) Bill, 2015, set to be introduced in the Parliament’s Winter Session, 2015, proposes much needed updates to the Drugs and Cosmetics Act, 1940. The Bill, 2015 broadens the scope of the government’s powers and introduces checks and balances in the manufacture, import, distribution and sale of drugs and cosmetics in India. Clinical trials are set to be overseen by the Ethics Committee, constituted under the Bill. The Committee will also have powers to audit clinical trials and make site visits to ensure safety and well being of participants. Greater regulation and oversight, stricter punishments and vigilance outline the proactive stance the Bill proposes for the government.

Tags : DRUG AND COSMETICS BILL 2015 ETHICS COMMITTEE

Share :